US5256141A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biological material deployment method and apparatus
Assignee: Individual
•
Filing: 1992-12-22
•
Granted: 1993-10-26
•
Expires: 2012-12-22
Abstract
Abstract The invention involves a system for the deployment of biologically active materials in a bodily passage, particularly in vascular wall tissue, in the form of an elongated multi-lumen catheter having a plurality of serially situated functional zones. One embodiment includes an externally accessed dispersion zone adapted to address a vascular segment and having a dispersion chamber subtending a major arc of the vascular circumference provided with a pattern of openings for deploying biologically active materials in the vascular segment and supplied through an externally connected lumen. An electrode member is provided associated with the dispersion zone for applying a controlled electrical charge to the biologically active material at the point of deployment. A pair of spaced inflatable balloons define proximal and distal occlusion zones for temporarily occluding normal vascular blood flow in the vascular segment during deployment of the biologically active materials. A flow bypass lumen connects proximal and distal infusion port zones flanking the occlusion zones and maintaining blood flow about and beyond the vascular segment during occlusion. A control system is provided for controlling operation of the deployment system including electrical input capable of the time-variable modulation of the charge applied by the electrode means.
Inventors
- 👤 Nelson Gencheff
- 👤 Carl W. Christensen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:00
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/0021; A61M25/0023; A61M25/0026; A61M25/0032; A61B; A61B17/00; A61B17/22; A61B2017/22001; A61B2017/22002; A61B2017/22051; A61B2017/22054; A61B2017/22082; A61B2017/22084; A61B90/00; A61B90/39; A61M25/10; A61M2025/1043; A61M2025/1052; A61M2025/1097; A61M25/0029; A61M25/1011
Claims Analysis
Total Claims: 29
Claim 1
Independent Claim
199 words
A system for the deployment of biologically active material in vascular wall tissue of a vascular segment of interest, the device being in the form of an elongated multi-lumen catheter having a plurality of serially situated functional zones comprising: an externally accessed dispersion zone adapted to address a vascular segment and having a perforated dispersion lumen chamber subtending a major arc of the vascular circumference provided with a pattern of openings for deploying biologically active materials in the vascular segment supplied through an externally connected lumen; an electrode means with the dispersion zone for applying a controlled electrical charge to the biologically active material at the point of deployment; a pair of spaced inflatable balloons defining a pair of occlusion zones for temporarily occluding normal vascular blood flow in the vascular segment of interest during deployment of the biologically active materials; flow bypass means comprising a lumen connecting proximal and distal infusion port zones for maintaining at least a minimum blood flow about and beyond the vascular segment of interest during the occlusion thereof; and control interface means for controlling operation of the system including means capable of the time-variable modulation of the charge applied by the electrode means.
Claim 2
Independent Claim
199 words
A system for the deployment of biologically active material in vascular wall tissue of a vascular segment of interest, the device being in the form of an elongated multi-lumen catheter having a plurality of serially situated functional zones comprising: an externally accessed dispersion zone adapted to address a vascular segment and having a perforated dispersion lumen chamber subtending a major arc of the vascular circumference provided with a pattern of openings for deploying biologically active materials in the vascular segment supplied through an externally connected lumen; an electrode means with the dispersion zone for applying a controlled electrical charge to the biologically active material at the point of deployment; a pair of spaced inflatable balloons defining a pair of occlusion zones for temporarily occluding normal vascular blood flow in the vascular segment of interest during deployment of the biologically active materials; flow bypass means comprising a lumen connecting proximal and distal infusion port zones for maintaining at least a minimum blood flow about and beyond the vascular segment of interest during the occlusion thereof; and control interface means for controlling operation of the system including means capable of the time-variable modulation of the charge applied by the electrode means.
Claim 3
Dependent Claim
93 words
A vascular catheter adapted as a biologically active species deployment device comprising: a main catheter device having two spaced balloon elements expansible against adjacent walls to occlude flow in a vascular segment and define a deployment zone therebetween; a deployment zone further including; a deployment chamber for delivering biologically active materials to the vascular wall during the period of flow occlusion; an electrode means for delivering a charge to the biologically active material during the delivery thereof; and flow bypass means providing an alternate path for vascular flow around the occluded vascular segment.
Claim 4
Dependent Claim
93 words
A vascular catheter adapted as a biologically active species deployment device comprising: a main catheter device having two spaced balloon elements expansible against adjacent walls to occlude flow in a vascular segment and define a deployment zone therebetween; a deployment zone further including; a deployment chamber for delivering biologically active materials to the vascular wall during the period of flow occlusion; an electrode means for delivering a charge to the biologically active material during the delivery thereof; and flow bypass means providing an alternate path for vascular flow around the occluded vascular segment.
Claim 5
Dependent Claim
13 words
The system of claim 1 wherein the biologically active materials include endothelial cells.
Claim 6
Dependent Claim
13 words
The system of claim 2 wherein the biologically active materials include endothelial cells.
Claim 7
Dependent Claim
27 words
The system of claim 1 wherein the biologically active materials include material selected from the group consisting of metabolic activators and inhibitors and iontophoretic transportable pharmacologic agents.
Claim 8
Dependent Claim
27 words
The system of claim 2 wherein the biologically active materials include material selected from the group consisting of metabolic activators and inhibitors and iontophoretic transportable pharmacologic agents.
Claim 9
Dependent Claim
37 words
The system of claim 2 wherein the deployment chamber zone is part of an infusion lumen and subtends a major arc of the vascular circumference and the biologically active material is dispersed through a pattern of perforations.
Claim 10
Dependent Claim
21 words
The system of claim 7 wherein the electrode means further comprises control means capable of time-variable modulation of the applied charge.
Claim 11
Dependent Claim
29 words
The system of claim 7 wherein the electrode means forms a layer parallel to the deployment layer and contains openings permitting the delivery of the biologically active material therethrough.
Claim 12
Dependent Claim
21 words
The system of claim 9 wherein the electrode means further comprises control means capable of time-variable modulation of the applied charge.
Claim 13
Dependent Claim
13 words
The system of claim 10 wherein the biologically active materials include endothelial cells.
Claim 14
Dependent Claim
29 words
The system of claim 1 wherein the electrode means forms a layer parallel to the deployment layer and contains openings permitting the delivery of the biologically active material therethrough.
Claim 15
Dependent Claim
28 words
The system of claim 1 wherein the flow bypass means includes an elongated lumen connecting perfusion ports proximal and distal of the means for temporarily occluding blood flow.
Claim 16
Dependent Claim
28 words
The system of claim 2 wherein the flow bypass means includes an elongated lumen connecting perfusion ports proximal and distal of the means for temporarily occluding blood flow.
Claim 17
Dependent Claim
12 words
The system of claim 1 wherein the major arc is about 240°.
Claim 18
Dependent Claim
12 words
The system of claim 9 wherein the major arc is about 240°.
Claim 19
Independent Claim
182 words
A method of providing iontophoretic transport to deliver biologically active material to a vascular segment of interest to restore vascular endothelium vitality in such specific segments of blood vessels comprising the steps of: determining a vascular segment of interest to be treated; navigating a vascular catheter device having spaced balloon elements expansible against the vessel walls to occlude blood flow therebetween, a chamber for delivering biologically active species to the vascular segment between the balloon elements, means for providing and delivering an electrical charge to the biologically active species during the deployment thereof and flow bypass means establishing an alternate path for flow about the occluded vascular segment to the predetermined vascular segment of interest; expanding the balloon to occlude flow in the vascular segment of interest and establish bypass flow; dispersing the biologically active species while using the electrode to deliver a charge to the material as desired; deflating the balloons restoring normal vascular flow and removing the catheter device after a predetermined time necessary for the biologically active species to be sufficiently assimilated to be unaffected by normal vascular flow.
Claim 20
Independent Claim
182 words
A method of providing iontophoretic transport to deliver biologically active material to a vascular segment of interest to restore vascular endothelium vitality in such specific segments of blood vessels comprising the steps of: determining a vascular segment of interest to be treated; navigating a vascular catheter device having spaced balloon elements expansible against the vessel walls to occlude blood flow therebetween, a chamber for delivering biologically active species to the vascular segment between the balloon elements, means for providing and delivering an electrical charge to the biologically active species during the deployment thereof and flow bypass means establishing an alternate path for flow about the occluded vascular segment to the predetermined vascular segment of interest; expanding the balloon to occlude flow in the vascular segment of interest and establish bypass flow; dispersing the biologically active species while using the electrode to deliver a charge to the material as desired; deflating the balloons restoring normal vascular flow and removing the catheter device after a predetermined time necessary for the biologically active species to be sufficiently assimilated to be unaffected by normal vascular flow.
Claim 21
Dependent Claim
30 words
The method of claim 17 wherein the biologically active species includes endothelial cells and further comprising the step of modulating the charge supplied to the materials in a predetermined manner.
Claim 22
Dependent Claim
14 words
The method of claim 15 wherein the charge is delivered in a time-variable manner.
Claim 23
Dependent Claim
14 words
The method of claim 18 wherein the charge is delivered in a time-variable manner.
Claim 24
Dependent Claim
12 words
The method of claim 17 wherein the charge is pulsed or constant.
Claim 25
Dependent Claim
12 words
The method of claim 20 wherein the charge is pulsed or constant.
Claim 26
Dependent Claim
13 words
The method of claim 18 wherein the charge applied is negative or positive.
Claim 27
Dependent Claim
13 words
The method of claim 22 wherein the charge applied is negative or positive.
Claim 28
Dependent Claim
27 words
The method of claim 17 wherein the biologically active material includes material selected from the group consisting of metabolic activators and/or inhibitors and iontophoretic transportable pharmacologic agents.
Claim 29
Dependent Claim
12 words
The method of claim 24 wherein the charge is pulsed or constant.
References Cited (Backward Citations)
DE2513868A1
Cited
SU721110A1
Cited
SU1228821A1
Cited
US4610662A
Cited
US4423725A
Cited
US4636195A
Cited
SU1069826A1
Cited
WO1985002779A1
Cited
US4785823A
Cited
US4944745A
Cited
DE3806458A1
Cited
GB2219510A
Cited
WO1991016945A1
Cited
US5129883A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-10-25 | 1997-04-26 | 1997-10-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-10-25 | 2001-04-26 | 2001-10-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-10-25 | 2005-04-26 | 2005-10-26 | $7700.00 | Window Closed / Lapsed |